Back
Target Corp. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison
Buy
54
TGT
Target Corp.
Last Price:
$97.76
Seasonality Move:
18.11%
Sell
26
ORKA
Oruka Therapeutics, Inc.
Last Price:
$30.39
Seasonality Move:
-9.32%
Buy
54
Target Corp. (TGT)
is a Buy
Is Target Corp. a Buy, Sell or Hold?
-
The current Target Corp. [TGT] share price is $97.75. The Score for TGT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
TGT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Oruka Therapeutics, Inc. (ORKA)
is a Sell
Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Oruka Therapeutics, Inc. [ORKA] share price is $30.31. The Score for ORKA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
ORKA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TGT Stock Price Chart
What is Target Corp.'s stock price today?
-
The Target Corp. share price today is $97.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TGT is experiencing slight selling pressure.
ORKA Stock Price Chart
What is Oruka Therapeutics, Inc.'s stock price today?
-
The Oruka Therapeutics, Inc. share price today is $30.31The current trend is moderately bullish and ORKA is experiencing slight buying pressure.
TGT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 26.83 | Buy |
| Relative Strength Index (14 RSI): | 58.13 | Buy |
| Chaikin Money Flow: | -484361 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (91.3 - 98.2) | Buy |
| Bollinger Bands (100): | (88.06 - 97.86) | Buy |
ORKA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 51.81 | Buy |
| Chaikin Money Flow: | 234570 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29 - 31.58) | Buy |
| Bollinger Bands (100): | (16.97 - 29.87) | Buy |
TGT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 97.11 | Buy |
| 20-day SMA: | 95.99 | Buy |
| 50-day SMA: | 92.95 | Buy |
| 200-day SMA: | 96.03 | Buy |
| 8-day EMA: | 89.64 | Buy |
| 20-day EMA: | 61.64 | Buy |
| 50-day EMA: | 32.13 | Buy |
| 200-day EMA: | 9.27 | Buy |
ORKA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.21 | Sell |
| 20-day SMA: | 30.53 | Sell |
| 50-day SMA: | 28.99 | Buy |
| 200-day SMA: | 17.48 | Buy |
| 8-day EMA: | 30.57 | Sell |
| 20-day EMA: | 30.26 | Buy |
| 50-day EMA: | 28.26 | Buy |
| 200-day EMA: | 21.62 | Buy |
Target Corp. Earnings Growth & TGT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.49 per share, a decrease this year of $1.38 per share, and an increase next year of $0.37 per share.
Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.32 per share, and a decrease next year of $0.42 per share.
Target Corp. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oruka Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||